Fernando Gomollón García-rekin lankidetzan egindako argitalpenak (5)

2019

  1. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results from the ENEIDA Registry

    Inflammatory Bowel Diseases, Vol. 25, Núm. 11, pp. 1862-1870

  2. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

    Therapeutic Advances in Gastroenterology, Vol. 12

  3. Increased risk of thiopurine-related adverse events in elderly patients with IBD

    Alimentary Pharmacology and Therapeutics, Vol. 50, Núm. 7, pp. 780-788

2007

  1. Crohn's disease: A review of current treatment with a focus on biologics

    Drugs, Vol. 67, Núm. 17, pp. 2511-2537

1991

  1. Comparative multicentric study of omeprazole versus ranitidine in the treatment of duodenal ulcer

    Revista Espanola de Enfermedades Digestivas, Vol. 80, Núm. 1, pp. 12-16